Sinterleukin 23 levels are increased in carotid atherosclerosis possible role for the interleukin 23/interleukin 17 axis

Stroke

Volumn 46, Issue 3, 2015, Pages 793-799

  Abbas, Azhar ^a   Gregersen, Ida ^a   Holm, Sverre ^a   Daissormont, Isabelle ^d   Bjerkeli, Vigdis ^a   Krohg Sørensen, Kirsten ^a   Skagen, Karolina R ^a   Dahl, Tuva B ^a   Russell, David ^a   Almås, Trine ^c   Bundgaard, Dorte ^c   Alteheld, Lars Holger ^b   Rashidi, Azita ^a   Dahl, Christen P ^a   Michelsen, Annika E ^a   Biessen, Erik A ^d   Aukrust, Pål ^a   Halvorsen, Bente ^a   Skjelland, Mona ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Ostfold Hospital Trust   (Norway)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Carotid stenosis; Inflammation; Interleukins

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR;

AGED; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR MORTALITY; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CELL LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

AGED; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID STENOSIS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-23; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; STROKE;

EID: 84929287607     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006516     Document Type: Article

References (26)

1. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27:493-501. doi: 10.1159/000210432.
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123:e18-e209. doi: 10.1161/CIR.0b013e3182009701.
3. Pelisek J, Eckstein HH, Zernecke A. Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke. Arch Immunol Ther Exp (Warsz). 2012;60:431-442. doi: 10.1007/s00005-012-0192-z.
4. Mathiesen EB, Bønaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromsø study. Circulation. 2001;103:2171-2175.
5. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317-325. doi: 10.1038/nature10146.
6. Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, Øie E, et al. Atherosclerotic plaque stability-what determines the fate of a plaque? Prog Cardiovasc Dis. 2008;51:183-194. doi: 10.1016/j. pcad.2008.09.001.
7. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715-725.
8. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002;168:5699-5708.
9. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233-240. doi: 10.1084/jem.20041257.
10. Duvallet E, Semerano L, Assier E, Falgarone G, Boissier MC. Interleukin-23: a key cytokine in inflammatory diseases. Ann Med. 2011;43:503-511. doi: 10.3109/07853890.2011.577093.
11. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006;116:1310-1316. doi: 10.1172/JCI21404.
12. Rong C, Hu W, Wu FR, Cao XJ, Chen FH. Interleukin-23 as a potential therapeutic target for rheumatoid arthritis. Mol Cell Biochem. 2012;361:243-248. doi: 10.1007/s11010-011-1109-6.
13. Mudigonda P, Mudigonda T, Feneran AN, Alamdari HS, Sandoval L, Feldman SR. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis. Dermatol Online J. 2012;18:1.
14. Erbel C, Dengler TJ, Wangler S, Lasitschka F, Bea F, Wambsganss N, et al. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res Cardiol. 2011;106:125-134. doi: 10.1007/s00395-010-0135-y.
15. Ma S, Zhong D, Chen H, Zheng Y, Sun Y, Luo J, et al. The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23/IL-17-mediated ischemic stroke in mice. J Neuroimmunol. 2013;257:28-35. doi: 10.1016/j.jneuroim.2013.01.007.
16. David A, Saitta S, De Caridi G, Benedetto F, Massara M, Risitano DC, et al. Interleukin-23 serum levels in patients affected by peripheral arterial disease. Clin Biochem. 2012;45:275-278. doi: 10.1016/j. clinbiochem.2011.12.010.
17. Zhang M, Cai ZR, Zhang B, Cai X, Li W, Guo Z, et al. Functional polymorphisms in interleukin-23 receptor and susceptibility to coronary artery disease. DNA Cell Biol. 2014;33:891-897. doi: 10.1089/dna.2014.2573.
18. Khojasteh-Fard M, Abolhalaj M, Amiri P, Zaki M, Taheri Z, Qorbani M, et al. IL-23 gene expression in PBMCs of patients with coronary artery disease. Dis Markers. 2012;33:289-293. doi: 10.3233/DMA-2012-00933.
19. Group ECPS. Carotid artery plaque composition-relationship to clinical presentation and ultrasound b-mode imaging. European carotid plaque study group. Eur J Vasc Endovasc Surg. 1995;10:23-30.
20. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229:340-346. doi: 10.1148/radiol.2292030516.
21. Breland UM, Michelsen AE, Skjelland M, Folkersen L, Krohg-Sørensen K, Russell D, et al. Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovasc Res. 2010;86:265-273. doi: 10.1093/cvr/cvq044.
22. Döring Y, Zernecke A. Plasmacytoid dendritic cells in atherosclerosis. Front Physiol. 2012;3:230. doi: 10.3389/fphys.2012.00230.
23. Chen S, Crother TR, Arditi M. Emerging role of IL-17 in atherosclerosis. J Innate Immun. 2010;2:325-333. doi: 10.1159/000314626.
24. Qu N, Xu M, Mizoguchi I, Furusawa J-i, Kaneko K, Watanabe K, et al. Pivotal roles of t-helper 17-related cytokines, il-17, il-22, and il-23, in inflammatory diseases. Clin Dev Immunol. 2013;2013:13.
25. Maloy KJ. The interleukin-23/interleukin-17 axis in intestinal inflammation. J Intern Med. 2008;263:584-590. doi: 10.1111/j.1365-2796.2008.01950.x.
26. Subramanian M, Thorp EB, Tabas I. Identification of a non-growth factor role for gm-csf in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through il-23 signaling Circ Res. 2015;116:e13-24. doi: 10.1161/CIRCRESAHA.116.304794.